Home » Healthcare » Pharmaceuticals » Gamma Aminobutyric Acid Analogs Market

Gamma Aminobutyric Acid Analogs Market By Indications (Anxiety Disorders, Epilepsy, Insomnia, Neuropathic Pain, Muscle Spasms) By Drug Type (Benzodiazepines, Non-Benzodiazepines, Barbiturates, Antiepileptic Drugs (AEDs) – Growth, Share, Opportunities & Competitive Analysis, 2018 – 2028

Price: $4999

Published: | Report ID: 22375 | Report Format : PDF

Executive Summary

Market Definition

The pharmaceutical and healthcare industry’s division that deals with medications or substances that are structurally similar to gamma-aminobutyric acid, a naturally occurring neurotransmitter in the central nervous system, is known as the gamma-aminobutyric acid analogs market. It is well recognized that GABA has inhibitory effects on the brain, which serve to control neuronal activity and maintain a balance between excitement and inhibition.

Market Overview

The market for gamma-aminobutyric acid analogs has been expanding steadily in recent years, and between 2023 and 2030, it is anticipated to rise at a CAGR of xx%. The market was estimated to be worth USD xx million in 2022, and it is anticipated to be worth USD xx million in 2030.

The calming effect of benzodiazepines is caused by the neurotransmitter GABA (Gamma-Aminobutyric Acid), which is enhanced by these medicines. In many countries around the world, doctors frequently prescribe benzodiazepines because they help to treat anxiety disorders, prevent seizures, induce sleep, and are also used to sedate patients before general anesthesia or surgery. A rise in the elderly population, a hectic lifestyle, and everyday routines are all important causes of mental disturbance, which can lead to diseases like anxiety, mania, and panic disorders.

Due to an increase in the frequency of anxiety, seizures, and sleeplessness, as well as an increase in concern for the avoidance of stress and related diseases, the demand for benzodiazepine medicines is growing quickly. These are the factors that are anticipated to boost the growth of the global market.

The need for new and inventive therapies for neurological illnesses is growing as a result of increased healthcare investment by both governments and individuals. Since several of these conditions have a viable therapy option in GABA analogs, the market is expanding.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Insights

  • The global demand for gamma-aminobutyric acid analogs was valued at USD xx million in 2022 and is expected to reach USD xx million in 2030, growing at a CAGR of xx% between 2023 and 2030.
  • Anxiety disorders are the leading segment of indications. Epilepsy, on the other hand, is expected to grow at a strong CAGR.
  • The leading drug type segment is benzodiazepines.
  • The CAGR for the oral administration route is expected to be the highest during the projection period.
  • During the forecast time frame, the adult category is likely to have the highest CAGR.
  • During the forecast period, hospitals and clinics are estimated to have the greatest CAGR.
  • North America dominated the gamma-aminobutyric acid analogs market.
  • Europe is predicted to be the second-largest region in the gamma-aminobutyric acid analogs market.
  • In the market for gamma-aminobutyric acid analogs, Asia Pacific is anticipated to grow at the fastest rate.
  • Patients prefer oral drug formulations, and both oral and injectable GABA analogs are readily available. The need for oral gamma-aminobutyric acid analogs is being driven by this.
  • The top potential for advancement in the market for gamma-aminobutyric acid analogs is the creation of GABA analog-based items for the reduction of anxiety and stress, as well as the investigation and development of GABA analogs as sleep aids.

Segmentation by Indications

  • By indications, anxiety disorders are the market leader. GABA analogs have been researched for their potential to treat social phobia and related forms of social anxiety. They could aid in lowering the social situational anxiety that comes with anticipation.
  • During the projected period, the epilepsy category is anticipated to exhibit a sizable CAGR. For the treatment of pediatric epilepsy, particularly specific forms of childhood epilepsy syndromes, GABA analogs may be taken into consideration. Traditional AEDs might not work effectively for some disorders.
  • Other indications, such as insomnia, neuropathic pain, and muscle spasms, also contribute to the demand for gamma-aminobutyric acid analogs.

Segmentation by Drug Type

  • The main drug type category is benzodiazepines. Anxiety, sleeplessness, seizures, and other problems can be temporarily controlled with the use of benzodiazepines, a group of drugs.
  • The barbiturates category is likely to register a significant CAGR during the period of forecasting. Gamma-aminobutyric acid (GABA), a neurotransmitter that lowers neuronal activity in the brain, has inhibitory effects that are enhanced by barbiturates. Barbiturates cause drowsiness, promote sleep, and lower anxiety by enhancing the inhibitory effects of GABA.
  • Other drug types, such as non-benzodiazepines and antiepileptic drugs (AEDs), also contribute to the demand for gamma-aminobutyric acid analogs.

Segmentation by Administration Route

  • The category for the oral administration route is anticipated to experience the highest CAGR in the projection period. Most people find oral administration convenient and comfortable. It is a popular way of administering medication to oneself because it does not require the use of needles or injections.
  • Another administration route, such as intravenous (IV), also contributes to the demand for gamma-aminobutyric acid analogs.

Segmentation by Patient Population

  • During the projection period, the adult category is likely to have the highest CAGR. Adults experiencing alcohol withdrawal may benefit from using GABA analogs as part of their therapy regimen. They could aid in reducing anxiety and seizure activity, which are signs of alcohol withdrawal syndrome.
  • Other patient populations, such as pediatrics, also contribute to the demand for gamma-aminobutyric acid analogs.

Segmentation by End-users

  • Hospitals and clinics will be expected to have the foremost CAGR during the prediction period. Gamma-aminobutyric acid (GABA) analogs may have a small number of clinical uses in clinics and hospitals, mostly for particular medical conditions and under the direction of medical specialists.
  • Other end-users, such as psychiatrists, neurologists and pharmacies, also contribute to the demand for gamma-aminobutyric acid analogs.

Segmentation by Region

  • The gamma-aminobutyric acid analogs market was led by North America. GABA-enriched functional meals and drinks were becoming more and more popular. Products that not only gave nutrition but also benefits for relaxation and mood-lifting attracted the interest of North American customers.
  • Europe is estimated to rank second in terms of market size for gamma-aminobutyric acid analogs.
  • Asia Pacific will witness the most rapid growth in the gamma-aminobutyric acid analogs market.
  • The rest of the world, including Latin America, the Middle East, and Africa, meets the rest of the gamma-aminobutyric acid analogs demand.

The usage of social media helps caretakers and patients with neurological illnesses communicate with one another. As a result, there are more options for instruction and assistance, which is increasing demand for gamma-aminobutyric acid analogs.

During the time of forecasting, North America will probably rule the gamma-aminobutyric acid analogs market. Companies in North America are also creating novel GABA analog formulations that are more bioavailable and have longer half-lives. They might become more practical and simple to utilize as a result. For the treatment of epilepsy, Sanofi is creating ganaxolone, a GABA analog, in North America. For the treatment of anxiety and insomnia in North America, G.W. Pharmaceuticals is creating the GABA analog nabilone.

The Asia Pacific area is projected to show the fastest growth throughout the forecast time frame. The growing significance of emotional well-being and understanding of mental health issues has grown across the Asia Pacific. The usage of GABA analogs to treat stress and anxiety may have been influenced by this trend.

Businesses in the Asia Pacific region had the opportunity to access a wider audience due to the expansion of e-commerce platforms. Online sales of wellness aids and dietary supplements were significant.

Kampo medicine is a name for Japan’s extensive herbal medicinal heritage. Examining possible partnerships between conventional herbal treatments and GABA analogs could create novel opportunities.

Key Highlights of the Report

The global gamma-aminobutyric acid analogs market is segmented by indications, drug type, administration route, patient population, end-users, and region. As far as the indications are concerned, anxiety disorders are the market spearhead. Benzodiazepines are the top drug type segment. During the forecast period, the oral administration route category is expected to grow at the highest CAGR. The hospitals and clinics are anticipated to experience the highest CAGR during the forecast period. North America is driving the gamma-aminobutyric acid analogs market growth.

The mechanisms underlying neurological diseases and the possible targets for GABA analogs are being better understood due to developments in brain imaging technology. This is stimulating innovation in the market for gamma-aminobutyric acid (GABA) analogs. More young people and people with greater levels of physical activity are becoming patients with neurological illnesses. The requirement for gamma-aminobutyric acid analogs is growing as a result.

However, according to forecasts, North America will hold the largest share of the market for gamma-aminobutyric acid analogs globally. The positive effects of GABA for a number of ailments, including anxiety, sleeplessness, and discomfort, are becoming more widely known. This is increasing popularity in North America for GABA supplements and other goods. Additionally, the Asia-Pacific (APAC) region is assumed to have the market’s sharpest growth. Companies placed a strong emphasis on labeling, sourcing, and quality control transparency in an effort to win over the trust of Asia Pacific customers, who were starting to become pickier about the components in products.

Which Key Factors Are Driving The Global Gamma-Aminobutyric Acid Analogs Market?

The emergence of social media, the increase of digital health, government assistance, and a robust product pipeline are the fundamental factors stimulating the market for gamma-aminobutyric acid analogs.

What Are The Key Challenges In The Global Market For Gamma-Aminobutyric Acid Analogs?

Competing products and the side effects and safety concerns are some of the challenges hindering the growth of the market for gamma-aminobutyric acid analogs.

What Market Opportunities Exist For Gamma-Aminobutyric Acid Analogs Globally?

Gamma-aminobutyric acid analogs have prospects in the global market for research into uses for GABA analogs in anti-aging and skin rejuvenation, as well as research into GABA analogs for mood stabilization in situations like bipolar disorder.

Market Drivers

Several factors influence the market for gamma-aminobutyric acid analogs globally. The main factors influencing the market for gamma-aminobutyric acid analogs globally are as follows:

Growing Prevalence of Neurological Disorders

Globally, neurological conditions like epilepsy, anxiety disorders, insomnia, and neuropathic pain are becoming increasingly common because of a variety of variables like aging populations, changing lifestyles, and environmental factors. GABA analogs play a significant role in the treatment of many of these disorders, which frequently necessitate pharmaceutical therapies.

New applications for GABA analogs are continually being discovered through research and clinical investigations. The pharmaceutical business gains access to new markets and expands its potential for growth as a result of the expansion of these substances’ indications. GABA analogs, for instance, might be researched for ailments other than those they’re typically used for, such as mood disorders and specific forms of migraines.

Market Restraints

Several challenges could prevent the expansion of the global market for gamma-aminobutyric acid analogs. Among them are the following:

Limited Clinical Evidence

The effectiveness and safety of any pharmaceutical or dietary supplement are established by clinical trials and scientific investigations, which are of utmost importance. GABA analogs may have less credibility in the eyes of consumers and healthcare professionals due to the scant clinical data supporting them. Without solid clinical evidence, it may be difficult to persuade doctors to suggest these medications or for consumers to believe in their efficacy.

Before authorizing new medications or making health claims for dietary supplements, regulatory organizations like the FDA in the U.S. frequently require a significant amount of clinical data. Lack of such proof may cause regulatory obstacles and hold up product approvals or claim substantiation. Consequently, market entry and product development may be constrained.

Opportunities

The global market for gamma-aminobutyric acid analogs presents significant potential opportunities. The following is an example of these:

Anti-inflammatory drug Demand is rising

Since GABA analogues have been shown to have anti-inflammatory properties, they can be used to treat a variety of inflammatory conditions, such as arthritis, asthma, and inflammatory bowel disease. The rising incidence of inflammatory disorders such rheumatoid arthritis, inflammatory bowel diseases, psoriasis, ulcerative colitis, and others is one of the main factors driving market development. By 2040, the Centers for Disease Control and Prevention predict that 78 million adults in the U.S. will have arthritis that has been officially diagnosed. During the projected period, this is anticipated to drive the market. Additionally, the market is anticipated to be boosted by the increasing use of corticosteroids in the management of atopic dermatitis, chronic obstructive pulmonary disease (COPD), and asthma.

Competitive Landscape

Key Players

The global market for gamma-aminobutyric acid analogs is very competitive, with many powerful players. Some of the leading market participants and their corresponding market shares are listed below:

  • Pfizer, Inc.
  • Ralington pharma LLP
  • Arbor Pharmaceuticals, LLC
  • H. Lundbeck A/S
  • Marinus Pharmaceuticals Emerald Limited
  • Chemkart Co.
  • Rosemont Pharmaceuticals.
  • Sarv Biolabs Pvt.
  • Amneal Pharmaceuticals LLC.
  • Merck KgaA
  • Others

These companies give mergers and acquisitions, expanding their distribution network, and developing new products a priority in order to remain competitive in the market.

The leading competitors in the global market for gamma-aminobutyric acid analogs are constantly looking for ways to get an advantage by releasing new items and advancements.

In August 2022, Aquestive Therapeutics, Inc., a pharmaceutical business, got FDA approval for LibervantTM, a buccal film based on diazepam for the treatment of acute epileptic seizures.

In February 2021, Leading specialty pharmaceutical company Akorn stated that it would be reviewing potential strategic possibilities for its Consumer Health Business.

Summary of Key Findings

  • The market for gamma-aminobutyric acid analogs is predicted to have large growth prospects in emerging markets. This is brought on by the rising incidence of neurological illnesses in these areas and an ongoing need for novel and cutting-edge therapies.
  • The market is segmented by indications, drug type, administration route, patient population, end-users, and region.
  • An indication that is leading the market is anxiety disorders.
  • The most ubiquitous drug type fragment is benzodiazepines.
  • In terms of CAGR, the oral administration route is expected to grow at the fastest rate during the forecast period.
  • The category for adults will likely see the highest CAGR during the anticipated time frame.
  • North America is leading market development; the market is highly competitive with key players including Pfizer, Inc., Ralington Pharma LLP, Arbor Pharmaceuticals, LLC, H. Lundbeck A/S, Marinus Pharmaceuticals Emerald Limited, Chemkart Co., Rosemont Pharmaceuticals., Sarv Biolabs Pvt., Amneal Pharmaceuticals LLC., Merck KgaA, and others.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Future Outlook

  • Optimistic viewpoint for the global gamma-aminobutyric acid analogs market with noteworthy growth potential in the North American region.
  • One of the primary factors propelling the growth of the market for gamma-aminobutyric acid analogs is the expanding frequency of neurological illnesses.
  • The insufficient clinical data may act as a key constraint to the market’s growth in the near future.
  • Foremost companies must concentrate on product innovation, expanding their market reach, and maintaining competitive pricing to stay ahead.

Segmentation

  • By Indications
    • Anxiety Disorders
    • Epilepsy
    • Insomnia
    • Neuropathic Pain
    • Muscle Spasms
  • By Drug Type
    • Benzodiazepines
    • Non-Benzodiazepines
    • Barbiturates
    • Antiepileptic Drugs (AEDs)
  • By Administration Route
    • Oral
    • Intravenous (IV)
  • By Patient Population
    • Adults
    • Pediatrics
  • By End-users
    • Hospitals and Clinics
    • Psychiatrists and Neurologists
    • Pharmacies
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of the Middle East and Africa

Adjacent Markets

There are several related markets in the gamma-aminobutyric acid analogs industry with significant potential for revenue growth. The major markets adjacent to the gamma-aminobutyric acid analogs market –

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Market Introduction

 

2. Executive Summary

2.1. Market Snapshot: Global Gamma Aminobutyric Acid Analogs Market

2.1.1. Global Gamma Aminobutyric Acid Analogs Market, By Indications

2.1.2. Global Gamma Aminobutyric Acid Analogs Market, By Drug Type

2.1.3. Global Gamma Aminobutyric Acid Analogs Market, By Administration Route

2.1.4. Global Gamma Aminobutyric Acid Analogs Market, By Patient Population

2.1.5. Global Gamma Aminobutyric Acid Analogs Market, By End-users

2.1.6. Global Gamma Aminobutyric Acid Analogs Market, By Region

2.2. Insights from Primary Respondents

 

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Gamma Aminobutyric Acid Analogs Market Value, 2022-2030, (US$ Mn)

3.1.2. Y-o-Y Growth Trend Analysis

3.2. Market Dynamics

3.2.1. Gamma Aminobutyric Acid Analogs Market Drivers

3.2.2. Gamma Aminobutyric Acid Analogs Market Restraints

3.2.3. Gamma Aminobutyric Acid Analogs Market Opportunities

3.2.4. Major Gamma Aminobutyric Acid Analogs Industry Challenges

3.3. Growth and Development Patterns

3.4. Investment Feasibility Analysis

3.5. Market Opportunity Analysis

3.5.1. Indications

3.5.2. Drug Type

3.5.3. Administration Route

3.5.4. Patient Population

3.5.5. End-users

3.5.6. Geography

 

4. Market Competitive Landscape Analysis

4.1. Company Market Share Analysis, 2022

4.1.1. Global Gamma Aminobutyric Acid Analogs Market: Company Market Share, Value 2022

4.1.2. Global Gamma Aminobutyric Acid Analogs Market: Top 6 Company Market Share, Value 2022

4.1.3. Global Gamma Aminobutyric Acid Analogs Market: Top 3 Company Market Share, Value 2022

4.2. Global Gamma Aminobutyric Acid Analogs Market: Company Revenue Share Analysis, 2022

4.3. Company Assessment Metrics, 2022

4.3.1. Stars

4.3.2. Emerging Leaders

4.3.3. Pervasive Players

4.3.4. Participants

4.4. Startups/ SMEs Assessment Metrics, 2022

4.4.1. Progressive Companies

4.4.2. Responsive Companies

4.4.3. Dynamic Companies

4.4.4. Starting Blocks

4.5. Strategic Development

4.5.1. Acquisition and Mergers

4.5.2. New Product Launch

4.5.3. Regional Expansion

4.5.4. Partnerships

4.6. Key Player Product Matrix

4.7. Potential for New Players in the Global Gamma Aminobutyric Acid Analogs Market

 

5. Premium Insights

5.1. STAR (Situation, Task, Action, Results) Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Bargaining Power of Buyers/Consumers

5.2.3. Bargaining Power of Suppliers

5.2.4. Threat of Substitute Types

5.2.5. Intensity of Competitive Rivalry

5.3. PESTEL Analysis

5.3.1. Political Factors

5.3.2. Economic Factors

5.3.3. Social Factors

5.3.4. Technological Factors

5.3.5. Environmental Factors

5.3.6. Legal Factors

5.4. Key Market Trends

5.4.1. Demand Side Trends

5.4.2. Supply Side Trends

5.5. Value Chain Analysis

5.6. Technology Analysis

5.6.1. Research and development in the global market

5.6.2. Patent Analysis

5.6.3. Emerging technologies and their potential disruption to the market

5.7. Consumer Behaviour Analysis

5.7.1. Consumer Preferences and Expectations

5.7.2. Factors Influencing Consumer Buying Decisions

5.7.2.1. North America

5.7.2.2. Europe

5.7.2.3. Asia Pacific

5.7.2.4. Latin America

5.7.2.5. Middle East and Africa

5.7.3. Consumer Pain Points

5.8. Analysis and Recommendations

5.9. Adjacent Market Analysis

 

6. Market Positioning of Key Players, 2022

6.1. Company market share of key players, 2022

6.2. Competitive Benchmarking

6.3. Market Positioning of Key Vendors

6.4. Geographical Presence Analysis

6.5. Major Strategies Adopted by Key Players

6.5.1. Key Strategies Analysis

6.5.2. Mergers and Acquisitions

6.5.3. Partnerships

6.5.4. Product Launch

6.5.5. Geographical Expansion

6.5.6. Others

 

7. Impact Analysis of COVID 19 and Russia – Ukraine War on Gamma Aminobutyric Acid Analogs Market

7.1. Ukraine-Russia War Impact

7.1.1. Uncertainty and Economic Instability

7.1.2. Supply chain disruptions

7.1.3. Regional market shifts

7.1.4. Shift in government priorities

7.2. COVID-19 Impact Analysis

7.2.1. Supply Chain Disruptions

7.2.2. Demand Fluctuations

7.2.3. Shift in Product Mix

7.2.4. Reduced Industrial Activity

7.2.5. Regional Impact Analysis

7.2.5.1. North America

7.2.5.2. Europe

7.2.5.3. Asia Pacific

7.2.5.4. Latin America

7.2.5.5. Middle East and Africa

 

8. Global Gamma Aminobutyric Acid Analogs Market, By Indications

8.1. Global Gamma Aminobutyric Acid Analogs Market Overview, by Indications

8.1.1. Global Gamma Aminobutyric Acid Analogs Market Revenue Share, By Indications, 2022 Vs 2030 (in %)

8.2. Anxiety Disorders

8.2.1. Global Gamma Aminobutyric Acid Analogs Market, By Anxiety Disorders, By Region, 2022-2030 (US$ Mn)

8.2.2. Market Dynamics for Anxiety Disorders

8.2.2.1. Drivers

8.2.2.2. Restraints

8.2.2.3. Opportunities

8.2.2.4. Trends

8.3. Epilepsy

8.3.1. Global Gamma Aminobutyric Acid Analogs Market, By Epilepsy, By Region, 2022-2030 (US$ Mn)

8.3.2. Market Dynamics for Epilepsy

8.3.2.1. Drivers

8.3.2.2. Restraints

8.3.2.3. Opportunities

8.3.2.4. Trends

8.4. Insomnia

8.4.1. Global Gamma Aminobutyric Acid Analogs Market, By Insomnia, By Region, 2022-2030 (US$ Mn)

8.4.2. Market Dynamics for Insomnia

8.4.2.1. Drivers

8.4.2.2. Restraints

8.4.2.3. Opportunities

8.4.2.4. Trends

8.5. Neuropathic Pain

8.5.1. Global Gamma Aminobutyric Acid Analogs Market, By Neuropathic Pain, By Region, 2022-2030 (US$ Mn)

8.5.2. Market Dynamics for Neuropathic Pain

8.5.2.1. Drivers

8.5.2.2. Restraints

8.5.2.3. Opportunities

8.5.2.4. Trends

8.6. Muscle Spasms

8.6.1. Global Gamma Aminobutyric Acid Analogs Market, By Muscle Spasms, By Region, 2022-2030 (US$ Mn)

8.6.2. Market Dynamics for Muscle Spasms

8.6.2.1. Drivers

8.6.2.2. Restraints

8.6.2.3. Opportunities

8.6.2.4. Trends

 

9. Global Gamma Aminobutyric Acid Analogs Market, By Drug Type

9.1. Global Gamma Aminobutyric Acid Analogs Market Overview, by Drug Type

9.1.1. Global Gamma Aminobutyric Acid Analogs Market Revenue Share, By Drug Type, 2022 Vs 2030 (in %)

9.2. Benzodiazepines

9.2.1. Global Gamma Aminobutyric Acid Analogs Market, By Benzodiazepines, By Region, 2022-2030 (US$ Mn)

9.2.2. Market Dynamics for Benzodiazepines

9.2.2.1. Drivers

9.2.2.2. Restraints

9.2.2.3. Opportunities

9.2.2.4. Trends

9.3. Non-Benzodiazepines

9.3.1. Global Gamma Aminobutyric Acid Analogs Market, By Non-Benzodiazepines, By Region, 2022-2030 (US$ Mn)

9.3.2. Market Dynamics for Non-Benzodiazepines

9.3.2.1. Drivers

9.3.2.2. Restraints

9.3.2.3. Opportunities

9.3.2.4. Trends

9.4. Barbiturates

9.4.1. Global Gamma Aminobutyric Acid Analogs Market, By Barbiturates, By Region, 2022-2030 (US$ Mn)

9.4.2. Market Dynamics for Barbiturates

9.4.2.1. Drivers

9.4.2.2. Restraints

9.4.2.3. Opportunities

9.4.2.4. Trends

9.5. Antiepileptic Drugs (AEDs)

9.5.1. Global Gamma Aminobutyric Acid Analogs Market, By Antiepileptic Drugs (AEDs), By Region, 2022-2030 (US$ Mn)

9.5.2. Market Dynamics for Antiepileptic Drugs (AEDs)

9.5.2.1. Drivers

9.5.2.2. Restraints

9.5.2.3. Opportunities

9.5.2.4. Trends

 

10. Global Gamma Aminobutyric Acid Analogs Market, By Administration Route

10.1. Global Gamma Aminobutyric Acid Analogs Market Overview, by Administration Route

10.1.1. Global Gamma Aminobutyric Acid Analogs Market Revenue Share, By Administration Route, 2022 Vs 2030 (in %)

10.2. Oral

10.2.1. Global Gamma Aminobutyric Acid Analogs Market, By Oral, By Region, 2022-2030 (US$ Mn)

10.2.2. Market Dynamics for Oral

10.2.2.1. Drivers

10.2.2.2. Restraints

10.2.2.3. Opportunities

10.2.2.4. Trends

10.3. Intravenous (IV)

10.3.1. Global Gamma Aminobutyric Acid Analogs Market, By Intravenous (IV), By Region, 2022-2030 (US$ Mn)

10.3.2. Market Dynamics for Intravenous (IV)

10.3.2.1. Drivers

10.3.2.2. Restraints

10.3.2.3. Opportunities

10.3.2.4. Trends

 

11. Global Gamma Aminobutyric Acid Analogs Market, By Patient Population

11.1. Global Gamma Aminobutyric Acid Analogs Market Overview, by Patient Population

11.1.1. Global Gamma Aminobutyric Acid Analogs Market Revenue Share, By Patient Population, 2022 Vs 2030 (in %)

11.2. Adults

11.2.1. Global Gamma Aminobutyric Acid Analogs Market, By Adults, By Region, 2022-2030 (US$ Mn)

11.2.2. Market Dynamics for Adults

11.2.2.1. Drivers

11.2.2.2. Restraints

11.2.2.3. Opportunities

11.2.2.4. Trends

11.3. Pediatrics

11.3.1. Global Gamma Aminobutyric Acid Analogs Market, By Pediatrics, By Region, 2022-2030 (US$ Mn)

11.3.2. Market Dynamics for Pediatrics

11.3.2.1. Drivers

11.3.2.2. Restraints

11.3.2.3. Opportunities

11.3.2.4. Trends

 

12. Global Gamma Aminobutyric Acid Analogs Market, By End-users

12.1. Global Gamma Aminobutyric Acid Analogs Market Overview, by End-users

12.1.1. Global Gamma Aminobutyric Acid Analogs Market Revenue Share, By End-users, 2022 Vs 2030 (in %)

12.2. Hospitals and Clinics

12.2.1. Global Gamma Aminobutyric Acid Analogs Market, By Hospitals and Clinics, By Region, 2022-2030 (US$ Mn)

12.2.2. Market Dynamics for Hospitals and Clinics

12.2.2.1. Drivers

12.2.2.2. Restraints

12.2.2.3. Opportunities

12.2.2.4. Trends

12.3. Psychiatrists and Neurologists

12.3.1. Global Gamma Aminobutyric Acid Analogs Market, By Psychiatrists and Neurologists, By Region, 2022-2030 (US$ Mn)

12.3.2. Market Dynamics for Psychiatrists and Neurologists

12.3.2.1. Drivers

12.3.2.2. Restraints

12.3.2.3. Opportunities

12.3.2.4. Trends

12.4. Pharmacies

12.4.1. Global Gamma Aminobutyric Acid Analogs Market, By Pharmacies, By Region, 2022-2030 (US$ Mn)

12.4.2. Market Dynamics for Pharmacies

12.4.2.1. Drivers

12.4.2.2. Restraints

12.4.2.3. Opportunities

12.4.2.4. Trends

 

13. Global Gamma Aminobutyric Acid Analogs Market, By Region

13.1. Global Gamma Aminobutyric Acid Analogs Market Overview, by Region

13.1.1. Global Gamma Aminobutyric Acid Analogs Market, By Region, 2022 vs 2030 (in%)

13.2. Indications

13.2.1. Global Gamma Aminobutyric Acid Analogs Market, By Indications, 2022-2030 (US$ Mn)

13.3. Drug Type

13.3.1. Global Gamma Aminobutyric Acid Analogs Market, By Drug Type, 2022-2030 (US$ Mn)

13.4. Administration Route

13.4.1. Global Gamma Aminobutyric Acid Analogs Market, By Administration Route, 2022-2030 (US$ Mn)

13.5. Patient Population

13.5.1. Global Gamma Aminobutyric Acid Analogs Market, By Patient Population, 2022-2030 (US$ Mn)

13.6. End-users

13.6.1. Global Gamma Aminobutyric Acid Analogs Market, By End-users, 2022-2030 (US$ Mn)

 

14. North America Gamma Aminobutyric Acid Analogs Market Analysis

14.1. Overview

14.1.1. Market Dynamics for North America

14.1.1.1. Drivers

14.1.1.2. Restraints

14.1.1.3. Opportunities

14.1.1.4. Trends

14.2. North America Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2030(US$ Mn)

14.2.1. Overview

14.2.2. SRC Analysis

14.3. North America Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2030(US$ Mn)

14.3.1. Overview

14.3.2. SRC Analysis

14.4. North America Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2030(US$ Mn)

14.4.1. Overview

14.4.2. SRC Analysis

14.5. North America Gamma Aminobutyric Acid Analogs Market, by Patient Population, 2017-2030(US$ Mn)

14.5.1. Overview

14.5.2. SRC Analysis

14.6. North America Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2030(US$ Mn)

14.6.1. Overview

14.6.2. SRC Analysis

14.7. North America Gamma Aminobutyric Acid Analogs Market, by Country, 2022-2030 (US$ Mn)

14.7.1. North America Gamma Aminobutyric Acid Analogs Market, by Country, 2022 Vs 2030 (in%)

14.7.2. U.S.

14.7.3. Canada

14.7.4. Mexico

 

15. Europe Gamma Aminobutyric Acid Analogs Market Analysis

15.1. Overview

15.1.1. Market Dynamics for Europe

15.1.1.1. Drivers

15.1.1.2. Restraints

15.1.1.3. Opportunities

15.1.1.4. Trends

15.2. Europe Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2030(US$ Mn)

15.2.1. Overview

15.2.2. SRC Analysis

15.3. Europe Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2030(US$ Mn)

15.3.1. Overview

15.3.2. SRC Analysis

15.4. Europe Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2030(US$ Mn)

15.4.1. Overview

15.4.2. SRC Analysis

15.5. Europe Gamma Aminobutyric Acid Analogs Market, by Patient Population, 2017-2030(US$ Mn)

15.5.1. Overview

15.5.2. SRC Analysis

15.6. Europe Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2030(US$ Mn)

15.6.1. Overview

15.6.2. SRC Analysis

15.7. Europe Gamma Aminobutyric Acid Analogs Market, by Country, 2022-2030 (US$ Mn)

15.7.1. Europe Gamma Aminobutyric Acid Analogs Market, by Country, 2022 Vs 2030 (in%)

15.7.2. UK

15.7.3. France

15.7.4. Germany

15.7.5. Italy

15.7.6. Spain

15.7.7. Benelux

15.7.8. Russia

15.7.9. Rest of Europe

 

16. Asia Pacific Gamma Aminobutyric Acid Analogs Market Analysis

16.1. Overview

16.1.1. Market Dynamics for Asia Pacific

16.1.1.1. Drivers

16.1.1.2. Restraints

16.1.1.3. Opportunities

16.1.1.4. Trends

16.2. Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2030(US$ Mn)

16.2.1. Overview

16.2.2. SRC Analysis

16.3. Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2030(US$ Mn)

16.3.1. Overview

16.3.2. SRC Analysis

16.4. Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2030(US$ Mn)

16.4.1. Overview

16.4.2. SRC Analysis

16.5. Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Patient Population, 2017-2030(US$ Mn)

16.5.1. Overview

16.5.2. SRC Analysis

16.6. Asia Pacific Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2030(US$ Mn)

16.6.1. Overview

16.6.2. SRC Analysis

16.7. Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Country, 2022-2030 (US$ Mn)

16.7.1. Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Country, 2022 Vs 2030 (in%)

16.7.2. China

16.7.3. Japan

16.7.4. India

16.7.5. South Korea

16.7.6. South East Asia

16.7.7. Rest of Asia Pacific

 

17. Latin America Gamma Aminobutyric Acid Analogs Market Analysis

17.1. Overview

17.1.1. Market Dynamics for Latin America

17.1.1.1. Drivers

17.1.1.2. Restraints

17.1.1.3. Opportunities

17.1.1.4. Trends

17.2. Latin America Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2030(US$ Mn)

17.2.1. Overview

17.2.2. SRC Analysis

17.3. Latin America Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2030(US$ Mn)

17.3.1. Overview

17.3.2. SRC Analysis

17.4. Latin America Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2030(US$ Mn)

17.4.1. Overview

17.4.2. SRC Analysis

17.5. Latin America Gamma Aminobutyric Acid Analogs Market, by Patient Population, 2017-2030(US$ Mn)

17.5.1. Overview

17.5.2. SRC Analysis

17.6. Latin America Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2030(US$ Mn)

17.6.1. Overview

17.6.2. SRC Analysis

17.7. Latin America Gamma Aminobutyric Acid Analogs Market, by Country, 2022-2030 (US$ Mn)

17.7.1. Latin America Gamma Aminobutyric Acid Analogs Market, by Country, 2022 Vs 2030 (in%)

17.7.2. Brazil

17.7.3. Argentina

17.7.4. Rest of Latin America

 

18. Middle East Gamma Aminobutyric Acid Analogs Market Analysis

18.1. Overview

18.1.1. Market Dynamics for Middle East

18.1.1.1. Drivers

18.1.1.2. Restraints

18.1.1.3. Opportunities

18.1.1.4. Trends

18.2. Middle East Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2030(US$ Mn)

18.2.1. Overview

18.2.2. SRC Analysis

18.3. Middle East Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2030(US$ Mn)

18.3.1. Overview

18.3.2. SRC Analysis

18.4. Middle East Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2030(US$ Mn)

18.4.1. Overview

18.4.2. SRC Analysis

18.5. Middle East Gamma Aminobutyric Acid Analogs Market, by Patient Population, 2017-2030(US$ Mn)

18.5.1. Overview

18.5.2. SRC Analysis

18.6. Middle East Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2030(US$ Mn)

18.6.1. Overview

18.6.2. SRC Analysis

18.7. Middle East Gamma Aminobutyric Acid Analogs Market, by Country, 2022-2030 (US$ Mn)

18.7.1. Middle East Gamma Aminobutyric Acid Analogs Market, by Country, 2022 Vs 2030 (in%)

18.7.2. UAE

18.7.3. Saudi Arabia

18.7.4. Rest of Middle East

 

19. Africa Gamma Aminobutyric Acid Analogs Market Analysis

19.1. Overview

19.1.1. Market Dynamics for Africa

19.1.1.1. Drivers

19.1.1.2. Restraints

19.1.1.3. Opportunities

19.1.1.4. Trends

19.2. Africa Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2030(US$ Mn)

19.2.1. Overview

19.2.2. SRC Analysis

19.3. Africa Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2030(US$ Mn)

19.3.1. Overview

19.3.2. SRC Analysis

19.4. Africa Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2030(US$ Mn)

19.4.1. Overview

19.4.2. SRC Analysis

19.5. Africa Gamma Aminobutyric Acid Analogs Market, by Patient Population, 2017-2030(US$ Mn)

19.5.1. Overview

19.5.2. SRC Analysis

19.6. Africa Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2030(US$ Mn)

19.6.1. Overview

19.6.2. SRC Analysis

19.7. Africa Gamma Aminobutyric Acid Analogs Market, by Country, 2022-2030 (US$ Mn)

19.7.1. Africa Gamma Aminobutyric Acid Analogs Market, by Country, 2022 Vs 2030 (in%)

19.7.2. South Africa

19.7.3. Egypt

19.7.4. Rest of Africa

 

20. Company profiles

20.1. Pfizer, Inc.

20.1.1. Company Overview

20.1.2. Products/Services Portfolio

20.1.3. Geographical Presence

20.1.4. SWOT Analysis

20.1.5. Financial Summary

20.1.5.1. Market Revenue and Net Profit (2019-2022)

20.1.5.2. Business Segment Revenue Analysis

20.1.5.3. Geographical Revenue Analysis

20.2. Ralington pharma LLP

20.3. Arbor Pharmaceuticals, LLC

20.4. H. Lundbeck A/S

20.5. Marinus Pharmaceuticals Emerald Limited

20.6. Chemkart Co.

20.7. Rosemont Pharmaceuticals.

20.8. Sarv Biolabs Pvt.

20.9. Amneal Pharmaceuticals LLC.

20.10. Merck KgaA

20.11. Others

 

21. Research Methodology

21.1. Research Methodology

21.2. Phase I – Secondary Research

21.3. Phase II – Data Modelling

21.3.1. Company Share Analysis Model

21.3.2. Revenue Based Modelling

21.4. Phase III – Primary Research

21.5. Research Limitations

21.5.1. Assumptions

List of Figures

FIG. 1 Global Gamma Aminobutyric Acid Analogs Market: Research Methodology

FIG. 2 Market Size Estimation – Top Down & Bottom up Approach

FIG. 3 Global Gamma Aminobutyric Acid Analogs Market Segmentation

FIG. 4 Global Gamma Aminobutyric Acid Analogs Market, by Indications, 2022 (US$ Mn)

FIG. 5 Global Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2022 (US$ Mn)

FIG. 6 Global Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2022 (US$ Mn)

FIG. 7 Global Gamma Aminobutyric Acid Analogs Market, by Patient Population, 2022 (US$ Mn)

FIG. 8 Global Gamma Aminobutyric Acid Analogs Market, by End-users, 2022 (US$ Mn)

FIG. 9 Global Gamma Aminobutyric Acid Analogs Market, by Geography, 2022 (US$ Mn)

FIG. 10 Attractive Investment Proposition, by Indications, 2022

FIG. 11 Attractive Investment Proposition, by Drug Type, 2022

FIG. 12 Attractive Investment Proposition, by Administration Route, 2022

FIG. 13 Attractive Investment Proposition, by Patient Population, 2022

FIG. 14 Attractive Investment Proposition, by End-users, 2022

FIG. 15 Attractive Investment Proposition, by Geography, 2022

FIG. 16 Global Market Share Analysis of Key Gamma Aminobutyric Acid Analogs Market Manufacturers, 2022

FIG. 17 Global Market Positioning of Key Gamma Aminobutyric Acid Analogs Market Manufacturers, 2022

FIG. 18 Global Gamma Aminobutyric Acid Analogs Market Value Contribution, By Indications, 2022 & 2030 (Value %)

FIG. 19 Global Gamma Aminobutyric Acid Analogs Market, by Anxiety Disorders, Value, 2022-2030 (US$ Mn)

FIG. 20 Global Gamma Aminobutyric Acid Analogs Market, by Epilepsy, Value, 2022-2030 (US$ Mn)

FIG. 21 Global Gamma Aminobutyric Acid Analogs Market, by Insomnia, Value, 2022-2030 (US$ Mn)

FIG. 22 Global Gamma Aminobutyric Acid Analogs Market, by Neuropathic Pain, Value, 2022-2030 (US$ Mn)

FIG. 23 Global Gamma Aminobutyric Acid Analogs Market, by Muscle Spasms, Value, 2022-2030 (US$ Mn)

FIG. 24 Global Gamma Aminobutyric Acid Analogs Market Value Contribution, By Drug Type, 2022 & 2030 (Value %)

FIG. 25 Global Gamma Aminobutyric Acid Analogs Market, by Benzodiazepines, Value, 2022-2030 (US$ Mn)

FIG. 26 Global Gamma Aminobutyric Acid Analogs Market, by Non-Benzodiazepines, Value, 2022-2030 (US$ Mn)

FIG. 27 Global Gamma Aminobutyric Acid Analogs Market, by Barbiturates, Value, 2022-2030 (US$ Mn)

FIG. 28 Global Gamma Aminobutyric Acid Analogs Market, by Antiepileptic Drugs (AEDs), Value, 2022-2030 (US$ Mn)

FIG. 29 Global Gamma Aminobutyric Acid Analogs Market Value Contribution, By Administration Route, 2022 & 2030 (Value %)

FIG. 30 Global Gamma Aminobutyric Acid Analogs Market, by Oral, Value, 2022-2030 (US$ Mn)

FIG. 31 Global Gamma Aminobutyric Acid Analogs Market, by Intravenous (IV), Value, 2022-2030 (US$ Mn)

FIG. 32 Global Gamma Aminobutyric Acid Analogs Market Value Contribution, By Patient Population, 2022 & 2030 (Value %)

FIG. 33 Global Gamma Aminobutyric Acid Analogs Market, by Adults, Value, 2022-2030 (US$ Mn)

FIG. 34 Global Gamma Aminobutyric Acid Analogs Market, by Pediatrics, Value, 2022-2030 (US$ Mn)

FIG. 35 Global Gamma Aminobutyric Acid Analogs Market Value Contribution, By End-users, 2022 & 2030 (Value %)

FIG. 36 Global Gamma Aminobutyric Acid Analogs Market, by  Hospitals and Clinics, Value, 2022-2030 (US$ Mn)

FIG. 37 Global Gamma Aminobutyric Acid Analogs Market, by Psychiatrists and Neurologists, Value, 2022-2030 (US$ Mn)

FIG. 38 Global Gamma Aminobutyric Acid Analogs Market, by  Pharmacies, Value, 2022-2030 (US$ Mn)

FIG. 39 North America Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 40 U.S. Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 41 Canada Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 42 Mexico Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 43 Europe Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 44 Germany Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 45 France Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 46 U.K. Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 47 Italy Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 48 Spain Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 49 Benelux Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 50 Russia Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 51 Rest of Europe Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 52 Asia Pacific Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 53 China Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 54 Japan Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 55 India Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 56 South Korea Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 57 South-East Asia Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 58 Rest of Asia Pacific Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 59 Latin America Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 60 Brazil Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 61 Argentina Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 62 Rest of Latin America Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 63 Middle East Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 64 UAE Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 65 Saudi Arabia Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 66 Rest of Middle East Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 67 Africa Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 68 South Africa Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 69 Egypt Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

FIG. 70 Rest of Africa Gamma Aminobutyric Acid Analogs Market, 2022-2030 (US$ Mn)

 

List of Tables

TABLE 1 Market Snapshot: Global Gamma Aminobutyric Acid Analogs Market

TABLE 2 Global Gamma Aminobutyric Acid Analogs Market: Market Drivers Impact Analysis

TABLE 3 Global Gamma Aminobutyric Acid Analogs Market: Market Restraints Impact Analysis

TABLE 4 Global Gamma Aminobutyric Acid Analogs Market, by Competitive Benchmarking, 2022

TABLE 5 Global Gamma Aminobutyric Acid Analogs Market, by Geographical Presence Analysis, 2022

TABLE 6 Global Gamma Aminobutyric Acid Analogs Market, by Key Strategies Analysis, 2022

TABLE 7 Global Gamma Aminobutyric Acid Analogs Market, by Anxiety Disorders, By Region, 2017-2022 (US$ Mn)

TABLE 8 Global Gamma Aminobutyric Acid Analogs Market, by Anxiety Disorders, By Region, 2023-2030 (US$ Mn)

TABLE 9 Global Gamma Aminobutyric Acid Analogs Market, by Epilepsy, By Region, 2017-2022 (US$ Mn)

TABLE 10 Global Gamma Aminobutyric Acid Analogs Market, by Epilepsy, By Region, 2023-2030 (US$ Mn)

TABLE 11 Global Gamma Aminobutyric Acid Analogs Market, by Insomnia, By Region, 2017-2022 (US$ Mn)

TABLE 12 Global Gamma Aminobutyric Acid Analogs Market, by Insomnia, By Region, 2023-2030 (US$ Mn)

TABLE 13 Global Gamma Aminobutyric Acid Analogs Market, by Neuropathic Pain, By Region, 2017-2022 (US$ Mn)

TABLE 14 Global Gamma Aminobutyric Acid Analogs Market, by Neuropathic Pain, By Region, 2023-2030 (US$ Mn)

TABLE 15 Global Gamma Aminobutyric Acid Analogs Market, by Muscle Spasms, By Region, 2017-2022 (US$ Mn)

TABLE 16 Global Gamma Aminobutyric Acid Analogs Market, by Muscle Spasms, By Region, 2023-2030 (US$ Mn)

TABLE 17 Global Gamma Aminobutyric Acid Analogs Market, by Benzodiazepines, By Region, 2017-2022 (US$ Mn)

TABLE 18 Global Gamma Aminobutyric Acid Analogs Market, by Benzodiazepines, By Region, 2023-2030 (US$ Mn)

TABLE 19 Global Gamma Aminobutyric Acid Analogs Market, by Non-Benzodiazepines, By Region, 2017-2022 (US$ Mn)

TABLE 20 Global Gamma Aminobutyric Acid Analogs Market, by Non-Benzodiazepines, By Region, 2023-2030 (US$ Mn)

TABLE 21 Global Gamma Aminobutyric Acid Analogs Market, by Barbiturates, By Region, 2017-2022 (US$ Mn)

TABLE 22 Global Gamma Aminobutyric Acid Analogs Market, by Barbiturates, By Region, 2023-2030 (US$ Mn)

TABLE 23 Global Gamma Aminobutyric Acid Analogs Market, by Antiepileptic Drugs (AEDs), By Region, 2017-2022 (US$ Mn)

TABLE 24 Global Gamma Aminobutyric Acid Analogs Market, by Antiepileptic Drugs (AEDs), By Region, 2023-2030 (US$ Mn)

TABLE 25 Global Gamma Aminobutyric Acid Analogs Market, by Oral, By Region, 2017-2022 (US$ Mn)

TABLE 26 Global Gamma Aminobutyric Acid Analogs Market, by Oral, By Region, 2023-2030 (US$ Mn)

TABLE 27 Global Gamma Aminobutyric Acid Analogs Market, by Intravenous (IV), By Region, 2017-2022 (US$ Mn)

TABLE 28 Global Gamma Aminobutyric Acid Analogs Market, by Intravenous (IV), By Region, 2023-2030 (US$ Mn)

TABLE 29 Global Gamma Aminobutyric Acid Analogs Market, by Adults, By Region, 2017-2022 (US$ Mn)

TABLE 30 Global Gamma Aminobutyric Acid Analogs Market, by Adults, By Region, 2023-2030 (US$ Mn)

TABLE 31 Global Gamma Aminobutyric Acid Analogs Market, by Pediatrics, By Region, 2017-2022 (US$ Mn)

TABLE 32 Global Gamma Aminobutyric Acid Analogs Market, by Pediatrics, By Region, 2023-2030 (US$ Mn)

TABLE 33 Global Gamma Aminobutyric Acid Analogs Market, by Hospitals and Clinics, By Region, 2017-2022 (US$ Mn)

TABLE 34 Global Gamma Aminobutyric Acid Analogs Market, by Hospitals and Clinics, By Region, 2023-2030 (US$ Mn)

TABLE 35 Global Gamma Aminobutyric Acid Analogs Market, by Psychiatrists and Neurologists, By Region, 2017-2022 (US$ Mn)

TABLE 36 Global Gamma Aminobutyric Acid Analogs Market, by Psychiatrists and Neurologists, By Region, 2023-2030 (US$ Mn)

TABLE 37 Global Gamma Aminobutyric Acid Analogs Market, by Pharmacies, By Region, 2017-2022 (US$ Mn)

TABLE 38 Global Gamma Aminobutyric Acid Analogs Market, by Pharmacies, By Region, 2023-2030 (US$ Mn)

TABLE 39 Global Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 40 Global Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 41 Global Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 42 Global Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 43 Global Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 44 Global Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 45 Global Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 46 Global Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 47 Global Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 48 Global Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 49 Global Gamma Aminobutyric Acid Analogs Market, by Region, 2017-2022 (US$ Mn)

TABLE 50 Global Gamma Aminobutyric Acid Analogs Market, by Region, 2023-2030 (US$ Mn)

TABLE 51 North America Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 52 North America Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 53 North America Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 54 North America Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 55 North America Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 56 North America Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 57 North America Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 58 North America Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 59 North America Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 60 North America Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 61 North America Gamma Aminobutyric Acid Analogs Market, by Country, 2017-2022 (US$ Mn)

TABLE 62 North America Gamma Aminobutyric Acid Analogs Market, by Country, 2023-2030 (US$ Mn)

TABLE 63 United States Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 64 United States Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 65 United States Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 66 United States Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 67 United States Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 68 United States Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 69 United States Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 70 United States Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 71 United States Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 72 United States Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 73 Canada Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 74 Canada Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 75 Canada Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 76 Canada Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 77 Canada Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 78 Canada Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 79 Canada Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 80 Canada Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 81 Canada Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 82 Canada Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 83 Mexico Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 84 Mexico Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 85 Mexico Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 86 Mexico Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 87 Mexico Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 88 Mexico Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 89 Mexico Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 90 Mexico Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 91 Mexico Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 92 Mexico Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 93 Europe Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 94 Europe Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 95 Europe Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 96 Europe Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 97 Europe Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 98 Europe Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 99 Europe Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 100 Europe Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 101 Europe Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 102 Europe Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 103 Europe Gamma Aminobutyric Acid Analogs Market, by Country, 2017-2022 (US$ Mn)

TABLE 104 Europe Gamma Aminobutyric Acid Analogs Market, by Country, 2023-2030 (US$ Mn)

TABLE 105 Germany Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 106 Germany Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 107 Germany Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 108 Germany Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 109 Germany Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 110 Germany Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 111 Germany Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 112 Germany Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 113 Germany Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 114 Germany Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 115 France Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 116 France Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 117 France Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 118 France Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 119 France Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 120 France Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 121 France Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 122 France Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 123 France Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 124 France Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 125 United Kingdom Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 126 United Kingdom Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 127 United Kingdom Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 128 United Kingdom Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 129 United Kingdom Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 130 United Kingdom Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 131 United Kingdom Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 132 United Kingdom Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 133 United Kingdom Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 134 United Kingdom Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 135 Italy Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 136 Italy Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 137 Italy Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 138 Italy Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 139 Italy Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 140 Italy Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 141 Italy Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 142 Italy Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 143 Italy Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 144 Italy Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 145 Spain Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 146 Spain Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 147 Spain Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 148 Spain Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 149 Spain Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 150 Spain Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 151 Spain Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 152 Spain Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 153 Spain Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 154 Spain Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 155 Benelux Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 156 Benelux Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 157 Benelux Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 158 Benelux Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 159 Benelux Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 160 Benelux Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 161 Benelux Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 162 Benelux Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 163 Benelux Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 164 Benelux Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 165 Russia Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 166 Russia Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 167 Russia Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 168 Russia Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 169 Russia Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 170 Russia Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 171 Russia Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 172 Russia Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 173 Russia Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 174 Russia Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 175 Rest of Europe Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 176 Rest of Europe Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 177 Rest of Europe Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 178 Rest of Europe Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 179 Rest of Europe Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 180 Rest of Europe Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 181 Rest of Europe Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 182 Rest of Europe Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 183 Rest of Europe Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 184 Rest of Europe Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 185 Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 186 Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 187 Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 188 Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 189 Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 190 Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 191 Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 192 Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 193 Asia Pacific Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 194 Asia Pacific Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 195 China Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 196 China Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 197 China Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 198 China Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 199 China Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 200 China Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 201 China Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 202 China Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 203 China Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 204 China Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 205 Japan Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 206 Japan Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 207 Japan Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 208 Japan Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 209 Japan Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 210 Japan Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 211 Japan Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 212 Japan Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 213 Japan Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 214 Japan Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 215 India Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 216 India Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 217 India Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 218 India Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 219 India Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 220 India Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 221 India Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 222 India Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 223 India Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 224 India Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 225 South Korea Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 226 South Korea Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 227 South Korea Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 228 South Korea Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 229 South Korea Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 230 South Korea Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 231 South Korea Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 232 South Korea Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 233 South Korea Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 234 South Korea Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 235 South-East Asia Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 236 South-East Asia Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 237 South-East Asia Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 238 South-East Asia Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 239 South-East Asia Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 240 South-East Asia Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 241 South-East Asia Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 242 South-East Asia Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 243 South-East Asia Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 244 South-East Asia Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 245 Rest of Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 246 Rest of Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 247 Rest of Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 248 Rest of Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 249 Rest of Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 250 Rest of Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 251 Rest of Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 252 Rest of Asia Pacific Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 253 Rest of Asia Pacific Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 254 Rest of Asia Pacific Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 255 Latin America Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 256 Latin America Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 257 Latin America Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 258 Latin America Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 259 Latin America Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 260 Latin America Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 261 Latin America Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 262 Latin America Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 263 Latin America Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 264 Latin America Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 265 Brazil Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 266 Brazil Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 267 Brazil Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 268 Brazil Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 269 Brazil Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 270 Brazil Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 271 Brazil Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 272 Brazil Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 273 Brazil Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 274 Brazil Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 275 Argentina Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 276 Argentina Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 277 Argentina Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 278 Argentina Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 279 Argentina Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 280 Argentina Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 281 Argentina Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 282 Argentina Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 283 Argentina Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 284 Argentina Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 285 Rest of Latin America Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 286 Rest of Latin America Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 287 Rest of Latin America Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 288 Rest of Latin America Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 289 Rest of Latin America Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 290 Rest of Latin America Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 291 Rest of Latin America Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 292 Rest of Latin America Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 293 Rest of Latin America Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 294 Rest of Latin America Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 295 Middle East Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 296 Middle East Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 297 Middle East Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 298 Middle East Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 299 Middle East Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 300 Middle East Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 301 Middle East Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 302 Middle East Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 303 Middle East Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 304 Middle East Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 305 UAE Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 306 UAE Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 307 UAE Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 308 UAE Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 309 UAE Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 310 UAE Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 311 UAE Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 312 UAE Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 313 UAE Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 314 UAE Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 315 Saudi Arabia Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 316 Saudi Arabia Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 317 Saudi Arabia Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 318 Saudi Arabia Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 319 Saudi Arabia Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 320 Saudi Arabia Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 321 Saudi Arabia Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 322 Saudi Arabia Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 323 Saudi Arabia Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 324 Saudi Arabia Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 325 Rest of Middle East Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 326 Rest of Middle East Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 327 Rest of Middle East Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 328 Rest of Middle East Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 329 Rest of Middle East Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 330 Rest of Middle East Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 331 Rest of Middle East Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 332 Rest of Middle East Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 333 Rest of Middle East Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 334 Rest of Middle East Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 335 Africa Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 336 Africa Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 337 Africa Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 338 Africa Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 339 Africa Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 340 Africa Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 341 Africa Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 342 Africa Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 343 Africa Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 344 Africa Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 345 South Africa Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 346 South Africa Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 347 South Africa Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 348 South Africa Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 349 South Africa Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 350 South Africa Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 351 South Africa Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 352 South Africa Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 353 South Africa Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 354 South Africa Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 355 Egypt Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 356 Egypt Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 357 Egypt Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 358 Egypt Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 359 Egypt Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 360 Egypt Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 361 Egypt Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 362 Egypt Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 363 Egypt Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 364 Egypt Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

TABLE 365 Rest of Africa Gamma Aminobutyric Acid Analogs Market, by Indications, 2017-2022 (US$ Mn)

TABLE 366 Rest of Africa Gamma Aminobutyric Acid Analogs Market, by Indications, 2023-2030 (US$ Mn)

TABLE 367 Rest of Africa Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2017-2022 (US$ Mn)

TABLE 368 Rest of Africa Gamma Aminobutyric Acid Analogs Market, by Drug Type, 2023-2030 (US$ Mn)

TABLE 369 Rest of Africa Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2017-2022 (US$ Mn)

TABLE 370 Rest of Africa Gamma Aminobutyric Acid Analogs Market, by Administration Route, 2023-2030 (US$ Mn)

TABLE 371 Rest of Africa Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2017-2022 (US$ Mn)

TABLE 372 Rest of Africa Gamma Aminobutyric Acid Analogs Market, by Patient Population, By Region, 2023-2030 (US$ Mn)

TABLE 373 Rest of Africa Gamma Aminobutyric Acid Analogs Market, by End-users, 2017-2022 (US$ Mn)

TABLE 374 Rest of Africa Gamma Aminobutyric Acid Analogs Market, by End-users, 2023-2030 (US$ Mn)

Frequently Asked Questions

How big is the global market for gamma-aminobutyric acid analogs right now?

In 2022, the market for gamma-aminobutyric acid analogs was estimated to be worth USD xx million.

What is the gamma-aminobutyric acid analogs market’s anticipated growth rate from 2023 to 2030?

The market for gamma-aminobutyric acid analogs is anticipated to increase at a CAGR of xx% from 2023 to 2030, reaching USD xx million in 2030.

In terms of the indications, which market category is in the lead?

Anxiety disorders are the most popular category of indications.

Which segment is leading the market in terms of drug type?

Benzodiazepines, by the drug type, are the notable segment.

Which end-user segment is estimated to have the highest CAGR throughout the forecast period?

During the projection period, the hospitals and clinics category is anticipated to exhibit the highest CAGR.

In which region is the market for gamma-aminobutyric acid analogs expanding?

The gamma-aminobutyric acid analogs market was ruled by North America.

Who are the key participants in the market for gamma-aminobutyric acid analogs globally?

The top players include Pfizer, Inc., Ralington Pharma LLP, Arbor Pharmaceuticals, LLC, H. Lundbeck A/S, Marinus Pharmaceuticals Emerald Limited, Chemkart Co., Rosemont Pharmaceuticals., Sarv Biolabs Pvt., Amneal Pharmaceuticals LLC., Merck KgaA, and others.

What are the main market factors driving the gamma-aminobutyric acid analogs sector?

GABA analogs’ effectiveness, low risk of side effects, and rising popularity have all contributed to their growing acceptance. These are the main factors influencing the development of the global market.

What main market challenges prevent the gamma-aminobutyric acid analogs sector from growing?

Gamma-aminobutyric acid analogs market growth is being constrained by the lack of standardization, price sensitivity, and research and development costs.

What are the main market opportunities for the gamma-aminobutyric acid analogs sector?

GABA analogs are frequently found in nutritional supplements used for reducing stress, better sleep, and cognitive assistance. GABA analogs may have a place in the market for natural and herbal medicines, which is growing as more people look for substitutes for conventional drugs.

Trigeminal Neuralgia Treatment Market

Published:
Report ID: 11788

Pompe Disease Therapeutics Market

Published:
Report ID: 5989

Pre-Menstrual Syndrome Treatment Market

Published:
Report ID: 11248

Vial Adaptors for Reconstitution Drug Market

Published:
Report ID: 15561

Psychedelic Medicine Market

Published:
Report ID: 41606

Hospital Infection Prevention And Control Market

Published:
Report ID: 7217

Nanoparticle Formulation Market

Published:
Report ID: 41106

Animal Drug Compounding Market

Published:
Report ID: 40870

Antibiotics Market

Published:
Report ID: 40728

Conjugation and Labeling Services Market

Published:
Report ID: 40756

Antiviral Drugs Market

Published:
Report ID: 40681

Intravitreal Injectable Market

Published:
Report ID: 7250

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN